Products

ClipScreen

Turn boring screenshots into beautiful visuals

clipscreen.online Design / Photo Editing & Enhancement

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$9/mo
Lower than 57% of peersNiche median $9.9/mo
Creators
Niraj Vishwakarma
No social account linked
Launched
7mo ago
2026-04-12 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Make your screenshots look premium in seconds

    Apr 12 · 7mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-03-25

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pro Lifetime
$9/once
Unlimited screenshots & exports · All 15 premium backgrounds · Up to 3× resolution export

Trial: None · 1 paid tier ($9) · Observed 2026-11-06 · Pricing page

Entry price $9/mo, Lower than 57% of peers; “Photo Editing & Enhancement” median is $9.9/mo.View pricing benchmark

Website snapshots

Indexed 2026-04-12

Key pages

Desktop & mobile archive
clipscreen.online/ Snapshot 2026-11-07

Questions & evidence

How much does ClipScreen cost?
Pro Lifetime: $9/once. Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does ClipScreen get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is ClipScreen and what platforms does it support?
ClipScreen is catalogued under Photo Editing & Enhancement: Turn boring screenshots into beautiful visuals. Supported platforms: Web.

Related products in this category

Design / Photo Editing & Enhancement

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.